Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats

Overview of attention for article published in Journal of Bone and Mineral Metabolism, February 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,461 followers.

RT @Osteoporosis_NL: Novel bisphosphonate FYB-931 preferentially inhibits aortic calcification in vitD3-treated rats. Ishida K et al. JBMM…

09 Feb 2019

Reply Repost Favourite

Novel bisphosphonate FYB-931 preferentially inhibits aortic calcification in vitD3-treated rats. Ishida K et al. JBMM 2019 Feb 2 https://t.co/tDXDN1xc6W …FYB-931 vs etidronate: 10 times more potent; inhibited TRACP 5.2 times more potent and significantly

09 Feb 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.